RecruitingPhase 1

Understanding Ketamine's Dissociative Effects (KD Study)

United States20 participantsStarted 2021-07-26

Plain-language summary

The purpose of this study is to understand how ketamine brings about dissociative symptoms.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient in Stanford Epilepsy Monitoring Unit * Age \>18 years old. Exclusion Criteria: * Lifetime psychotic or bipolar disorder * Inability to speak, read or understand English * Pregnant or nursing females * Prior adverse ketamine response

What they're measuring

Number of participants with dissociative events during ketamine infusion as assessed by CADSS (Clinician-Administered Dissociative State Scale)

Timeframe: up to 1 week

Trial details

NCT IDNCT04861051

SponsorStanford University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-08-01

Contact for this trial

Arjay Cordero

650-580-9000 arjayc@stanford.edu

View on ClinicalTrials.gov More Epilepsy trials